Home › Funds › Frazier Life Sciences Management, L.P. › STTK
Frazier Life Sciences Management, L.P. position in STTK
SHATTUCK LABS INC · Health Care
Frazier Life Sciences Management, L.P. reported holding 3,750,000 shares of STTK (SHATTUCK LABS INC) in its Q2 2026 13F filing — a position valued at US$26.0M, representing 0.57% of its reported portfolio and ranking #30 among its reported holdings. Frazier Life Sciences Management, L.P. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Frazier Life Sciences Management, L.P.'s STTK position evolved
Frazier Life Sciences Management, L.P. first disclosed a stake in STTK in Q2 2026 at 3,750,000 shares (US$26.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.75M | $26.02M | New |
About STTK and 13F data
STTK (SHATTUCK LABS INC) is a Health Care company. 57 other funds we track also report a position in STTK — the largest reported positions include Redmile Group, LLC (US$47.8M), ORBIMED ADVISORS LLC (US$43.8M), Prosight Management, LP (US$41.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STTK
- Redmile Group, LLC 6.89M sh · $47.83M · Q2 2026
- ORBIMED ADVISORS LLC 6.31M sh · $43.76M · Q2 2026
- Prosight Management, LP 5.96M sh · $41.35M · Q2 2026
- NEXTBio Capital Management LP 3.73M sh · $25.87M · Q2 2026
- Deep Track Capital, LP 3.71M sh · $25.72M · Q2 2026
- CLARK ESTATES INC/NY 1.43M sh · $9.93M · Q2 2026
- Boxer Capital Management, LLC 1.00M sh · $6.94M · Q2 2026
- S&G Foundation 435.75K sh · $3.02M · Q2 2026
- West Tower Group, LLC 191.62K sh · $1.31M · Q3 2026
- LBJ Family Wealth Advisors, Ltd. 82.18K sh · $560.00K · Q3 2026
More on Frazier Life Sciences Management, L.P.
FAQ
How long has Frazier Life Sciences Management, L.P. held STTK?
Frazier Life Sciences Management, L.P. has disclosed STTK holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Frazier Life Sciences Management, L.P.'s current position in STTK?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 3.75M shares of STTK (SHATTUCK LABS INC), valued at $26.02M, representing 0.57% of its reported portfolio and ranking #30.
Has Frazier Life Sciences Management, L.P. been buying or selling STTK?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. newly opened its position in STTK.
Which other funds hold STTK?
Other major institutional holders of STTK include Redmile Group, LLC, ORBIMED ADVISORS LLC, Prosight Management, LP, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.